After decades of inconclusive results, researchers backed by Pfizer and Massachusetts General Hospital revealed that they had identified several genetic markers associated with depression earlier this month. It was the largest study of its kind, using data from more than 120,000 people.
{iframe}https://www.fastcompany.com/3062731/most-innovative-companies/23andmes-consumer-dna-data-gold-mine-is-starting-to-pay-off?utm_source=mailchimp&utm_medium=email&utm_campaign=tech-weekly-newsletter&position=6&partner=newsletter&campaign_date=08242016{/iframe}